DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Capillary Technologies Q1 Results: Earnings call scheduled for Aug 4

scanx.trade 59 min ago·28 Jul 2026, 4:23 pm

Capillary Technologies has announced its first-quarter results, with an earnings call scheduled for August 4. This meeting will provide investors with the company's detailed financial performance and management's outlook for the upcoming period.

This update is crucial for retail investors to gauge the company's current operational health and future growth trajectory. Analyzing the discussion during the call will help in understanding how Capillary plans to navigate the competitive landscape and its strategy for value creation.

Investors should watch for key metrics like revenue growth, profit margins, and management's commentary on market conditions. These details will be essential in forming an informed view of the stock's potential in the near future.